30 September, 2017 by The TZ Newswire Staff Comments Off on Could Bank of America’s Stock Hit $30 Soon?
Could Bank of America’s Stock Hit $30 Soon?
It’s almost hard to believe that Bank of America‘s (NYSE: BAC) stock could be closing in on $30 a share, but it is. The reason it’s hard to believe this is because, at this time last year, it was trading for well below $20 a share.
30 September, 2017 by The TZ Newswire Staff Comments Off on How oil powerhouse Nigeria escaped the clutches of recession — and why it may not last for long
How oil powerhouse Nigeria escaped the clutches of recession — and why it may not last for long
Nigeria’s had a lucky streak, but can it continue?
30 September, 2017 by The TZ Newswire Staff Comments Off on Oil Prices: Next Stop $85 a Barrel?
Oil Prices: Next Stop $85 a Barrel?
What a difference some new data makes. A few months ago, analysts were throwing in the towel on the oil market, with several slashing their price targets on crude and downgrading oil stocks.
30 September, 2017 by The TZ Newswire Staff Comments Off on Better Buy: Exelixis, Inc. vs. Immunogen, Inc.
Better Buy: Exelixis, Inc. vs. Immunogen, Inc.
It’s been a really good year for Exelixis (NASDAQ: EXEL). The biotech’s share price has jumped more than 60% so far in 2017, thanks to continued momentum for its kidney cancer drug Cabometyx. But it’s been a really great year for Immunogen (NASDAQ: IMGN): The stock has soared nearly 270%.
The past is the past, though. Which of these cancer-focused biotech stocks is the better choice for investors now? Here’s how Exelixis and Immunogen compare.
Image source: Getty Images.
30 September, 2017 by The TZ Newswire Staff Comments Off on Look Who Kalanick Just Appointed To The Uber Board Without Consulting Anyone
Look Who Kalanick Just Appointed To The Uber Board Without Consulting Anyone
It looks like Travis Kalanick is preparing for all-out war in the Uber boardroom.
30 September, 2017 by The TZ Newswire Staff Comments Off on 3 Biotech Stocks That Soared This Week: Are They Buys?
3 Biotech Stocks That Soared This Week: Are They Buys?
There’s nothing like good results from a clinical study to light a fire beneath a biotech stock. That’s what has happened with several biotechs over the last few days.
30 September, 2017 by The TZ Newswire Staff Comments Off on NVIDIA Has Its Eye on Smart Cities in China with New Alibaba Partnership
NVIDIA Has Its Eye on Smart Cities in China with New Alibaba Partnership
NVIDIA Corporation‘s (NASDAQ: NVDA) artificial intelligence (AI) prospects have continued to grow as the company uses its GPUs to build self-driving car hardware and software, smart cloud computing systems, and deep learning training for servers.